Conference Coverage
Conference Coverage
PACIFIC: Patterns of lung cancer progression suggest role for local ablative therapy
Approximately two-thirds of patients with distant progression had one or two new lesions.
Conference Coverage
Vitamin D does not improve bone density, structure in healthy patients
ORLANDO – Daily use for 2 years did not affect areal BMD in the whole body, femoral neck, total hip, or spine, or...
Conference Coverage
Machine learning–derived risk score predicts heart failure risk in diabetes patients
Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.
Conference Coverage
Semaglutide beats canagliflozin as second-line therapy for type 2 diabetes
BARCELONA –
Conference Coverage
First data VERIFY value of early combination therapy in type 2 diabetes
BARCELONA –
Conference Coverage
Even with no disease activity, recurrence risk near 50% when stopping DMTs for MS
STOCKHOLM – Younger patients had a significantly higher risk of recurrence when stopping disease modifying therapy.
Latest News
Milrinone beats dobutamine in extending survival in HF
PHILADELPHIA – Survival benefit favored milrinone regardless of indication for use in continuous outpatient intravenous inotropic therapy.
Conference Coverage
European cholesterol guidelines push LDL targets below 55 mg/dL
PARIS –
Conference Coverage
Newer drugs provide superior disease activity control in pediatric MS
STOCKHOLM – Study from U.S. Network of Pediatric MS Centers supports early use of newer disease-modifying therapies.
Conference Coverage
Most patients with RIS develop MS within 10 years
STOCKHOLM – The conversion rate jumps to 87% in the presence of four risk factors at baseline.